1706. Pro
Session: Interactive Session: Debate: Clinical Controversies
Friday, October 6, 2017: 5:05 PM
Room: 06AB
Timothy Wilkin, MD, MPH, FIDSA, Division of Infectious Diseases, Weill Cornell Medicine, New York, NY


Disclosures:

T. Wilkin, Bristol Myers Squibb: Grant Investigator , Research support
Glaxo Smith Kline/ViiV Healthcare: Consultant and Grant Investigator , Consulting fee and Research grant
Johnson&Johnson: Shareholder , Shareholder

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.